196 related articles for article (PubMed ID: 30216498)
1. Searching for biomarkers of chronic obstructive pulmonary disease using proteomics: The current state.
Cagnone M; Salvini R; Bardoni A; Fumagalli M; Iadarola P; Viglio S
Electrophoresis; 2019 Jan; 40(1):151-164. PubMed ID: 30216498
[TBL] [Abstract][Full Text] [Related]
2. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.
Casado B; Iadarola P; Luisetti M; Kussmann M
Expert Rev Proteomics; 2008 Oct; 5(5):693-704. PubMed ID: 18937559
[TBL] [Abstract][Full Text] [Related]
3. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
Chen H; Wang D; Bai C; Wang X
J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
[TBL] [Abstract][Full Text] [Related]
4. Advances in proteomic techniques for biomarker discovery in COPD.
Casado B; Luisetti M; Iadarola P
Expert Rev Clin Immunol; 2011 Jan; 7(1):111-23. PubMed ID: 21162654
[TBL] [Abstract][Full Text] [Related]
5. Biomarker discovery in asthma and COPD by proteomic approaches.
Rossi R; De Palma A; Benazzi L; Riccio AM; Canonica GW; Mauri P
Proteomics Clin Appl; 2014 Dec; 8(11-12):901-15. PubMed ID: 25186471
[TBL] [Abstract][Full Text] [Related]
6. Large-scale, ion-current-based proteomics investigation of bronchoalveolar lavage fluid in chronic obstructive pulmonary disease patients.
Tu C; Mammen MJ; Li J; Shen X; Jiang X; Hu Q; Wang J; Sethi S; Qu J
J Proteome Res; 2014 Feb; 13(2):627-639. PubMed ID: 24188068
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease.
Kohler M; Sandberg A; Kjellqvist S; Thomas A; Karimi R; Nyrén S; Eklund A; Thevis M; Sköld CM; Wheelock ÅM
J Allergy Clin Immunol; 2013 Mar; 131(3):743-51. PubMed ID: 23146379
[TBL] [Abstract][Full Text] [Related]
8. Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls.
Csanky E; Rühl R; Scholtz B; Vasko A; Takacs L; Hempel WM
Electrophoresis; 2009 Apr; 30(7):1228-34. PubMed ID: 19294692
[TBL] [Abstract][Full Text] [Related]
9. Lung proteomic biomarkers associated with chronic obstructive pulmonary disease.
Zhang YH; Hoopmann MR; Castaldi PJ; Simonsen KA; Midha MK; Cho MH; Criner GJ; Bueno R; Liu J; Moritz RL; Silverman EK
Am J Physiol Lung Cell Mol Physiol; 2021 Dec; 321(6):L1119-L1130. PubMed ID: 34668408
[TBL] [Abstract][Full Text] [Related]
10. Role of proteomics in the investigation of pulmonary fibrosis.
Govender P; Baugh JA; Pennington SR; Dunn MJ; Donnelly SC
Expert Rev Proteomics; 2007 Jun; 4(3):379-88. PubMed ID: 17552922
[TBL] [Abstract][Full Text] [Related]
11. Asthma and COPD proteomics: current approaches and future directions.
Terracciano R; Pelaia G; Preianò M; Savino R
Proteomics Clin Appl; 2015 Feb; 9(1-2):203-20. PubMed ID: 25504544
[TBL] [Abstract][Full Text] [Related]
12. Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease.
Aydindogan E; Penque D; Zoidakis J
Expert Rev Mol Diagn; 2019 Jan; 19(1):37-45. PubMed ID: 30560707
[No Abstract] [Full Text] [Related]
13. Mass spectrometry-based proteomics for pre-eclampsia and preterm birth.
Law KP; Han TL; Tong C; Baker PN
Int J Mol Sci; 2015 May; 16(5):10952-85. PubMed ID: 26006232
[TBL] [Abstract][Full Text] [Related]
14. Differential proteomic analysis of bronchoalveolar lavage fluid from lung transplant patients with and without chronic graft dysfunction.
Kosanam H; Sato M; Batruch I; Smith C; Keshavjee S; Liu M; Diamandis EP
Clin Biochem; 2012 Feb; 45(3):223-30. PubMed ID: 22206736
[TBL] [Abstract][Full Text] [Related]
15. Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD).
Moon JY; Leitao Filho FS; Shahangian K; Takiguchi H; Sin DD
Expert Rev Proteomics; 2018 Nov; 15(11):923-935. PubMed ID: 30362838
[TBL] [Abstract][Full Text] [Related]
16. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL
J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700
[TBL] [Abstract][Full Text] [Related]
17. Application of proteomics and peptidomics to COPD.
Pelaia G; Terracciano R; Vatrella A; Gallelli L; Busceti MT; Calabrese C; Stellato C; Savino R; Maselli R
Biomed Res Int; 2014; 2014():764581. PubMed ID: 24895607
[TBL] [Abstract][Full Text] [Related]
18. Bronchoalveolar Lavage: Quantitative Mass Spectrometry-Based Proteomics Analysis in Lung Diseases.
Carvalho AS; Matthiesen R
Methods Mol Biol; 2017; 1619():487-494. PubMed ID: 28674906
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in COPD.
Tzortzaki EG; Lambiri I; Vlachaki E; Siafakas NM
Curr Med Chem; 2007; 14(9):1037-48. PubMed ID: 17439401
[TBL] [Abstract][Full Text] [Related]
20. From proteomics to prescription-the search for COPD biomarkers.
Nicholas BL; O'Connor CD; Djukanovic R
COPD; 2009 Aug; 6(4):298-303. PubMed ID: 19811390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
